Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.396, 2003-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Abciximab invaluable for PCI in CHD in the UK
Inpharma, Vol. 1, Iss. 1371, 2003-01 ,pp. :
Access to resources
Recommend
Abciximab not so SWEET following PCI in CAD, diabetes
Inpharma, Vol. 1, Iss. 1476, 2005-01 ,pp. :
Abciximab beneficial in younger patients with ACS undergoing PCI
Inpharma, Vol. 1, Iss. 1569, 2007-01 ,pp. :
BRAVE researchers say abciximab of no benefit in PCI for STEMI
Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. :
Extra cost of abciximab justified in PCI?
Inpharma, Vol. 1, Iss. 1288, 2001-01 ,pp. :